Esther Martinborough
Directeur/Bestuurslid bij CODEXIS, INC.
Vermogen: 153 522 $ op 30-04-2024
Profiel
Esther Martinborough is an Independent Director at Codexis, Inc. since 2021.
She is also the Chief Scientific Officer at Escient Pharmaceuticals, Inc. since 2018.
Prior to her current positions, she worked as the Executive Director-Research at Receptos LLC from 2008 to 2018.
Dr. Martinborough holds a doctorate degree from the Swiss Federal Institute of Technology and a graduate degree from the University of California.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CODEXIS, INC.
0.08% | 18-04-2024 | 57 933 ( 0.08% ) | 153 522 $ | 30-04-2024 |
Actieve functies van Esther Martinborough
| Bedrijven | Functie | Begin |
|---|---|---|
| CODEXIS, INC. | Directeur/Bestuurslid | 02-02-2021 |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Hoofd Techniek/Wetenschap/O&O | 01-04-2023 |
Eerdere bekende functies van Esther Martinborough
| Bedrijven | Functie | Einde |
|---|---|---|
| RECEPTOS INC | Directeur/Bestuurslid | 01-01-2015 |
Opleiding van Esther Martinborough
| Swiss Federal Institute of Technology | Doctorate Degree |
| University of California | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CODEXIS, INC. | Process Industries |
| Bedrijven in privébezit | 2 |
|---|---|
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in San Diego, CA. | Health Technology |
